Stefan Dirnhofer
About
Stefan Dirnhofer is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology.
According to data from OpenAlex, Stefan Dirnhofer has authored 89 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 32 papers in Genetics and 31 papers in Oncology. Recurrent topics in Stefan Dirnhofer's work include Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Stefan Dirnhofer is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Stefan Dirnhofer collaborates with scholars based in Switzerland, Germany and United States. Stefan Dirnhofer's co-authors include Alexandar Tzankov, Luigi Terracciano, Luigi Tornillo, Darius Juškevičius, Michel Bihl, Abbas Agaimy, Anja Foerster, Arndt Hartmann, Thomas Menter and Alessandro Lugli and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.
In The Last Decade
Stefan Dirnhofer
85 papers receiving 1.6k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Stefan Dirnhofer Switzerland | 22 | 548 | 539 | 377 | 367 | 324 | 89 | 1.6k | ||
| Nicole Mentens Belgium | 22 | 307 0.6× | 449 0.8× | 619 1.6× | 766 2.1× | 360 1.1× | 33 | 2.4k | ||
| Haiyi Guo China | 12 | 447 0.8× | 743 1.4× | 429 1.1× | 350 1.0× | 318 1.0× | 28 | 1.3k | ||
| Xiaonan Hong China | 20 | 930 1.7× | 1.0k 1.9× | 416 1.1× | 248 0.7× | 309 1.0× | 71 | 1.7k | ||
| Anthony P. Conley United States | 26 | 240 0.4× | 774 1.4× | 1.0k 2.7× | 320 0.9× | 79 0.2× | 119 | 1.9k | ||
| Paola Casieri Italy | 19 | 255 0.5× | 624 1.2× | 497 1.3× | 389 1.1× | 144 0.4× | 43 | 1.5k | ||
| Ingrid Simonitsch‐Klupp Austria | 29 | 1.1k 2.0× | 586 1.1× | 263 0.7× | 356 1.0× | 376 1.2× | 93 | 2.4k | ||
| Jonathan Keith Killian United States | 23 | 234 0.4× | 382 0.7× | 478 1.3× | 725 2.0× | 93 0.3× | 62 | 1.6k | ||
| Amy Harlow United States | 9 | 123 0.2× | 537 1.0× | 692 1.8× | 442 1.2× | 81 0.3× | 10 | 1.6k | ||
| Kim Linton United Kingdom | 24 | 1.2k 2.1× | 1.1k 2.0× | 376 1.0× | 421 1.1× | 542 1.7× | 122 | 2.2k |
Countries citing papers authored by Stefan Dirnhofer
Since
Specialization
Citations
This map shows the geographic impact of Stefan Dirnhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Dirnhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Dirnhofer more than expected).
Fields of papers citing papers by Stefan Dirnhofer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Stefan Dirnhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Dirnhofer. The network helps show where Stefan Dirnhofer may publish in the future.
Co-authorship network of co-authors of Stefan Dirnhofer
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Dirnhofer. A scholar is included among the top collaborators of Stefan Dirnhofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Dirnhofer. Stefan Dirnhofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fend, Falko, Stefan Dirnhofer, Caoimhe Egan, et al.. (2025). Histiocytoses and reactive proliferations of histiocytes: current state of the art and evolving concepts—a report from the joint CSHP-EA4HP-SH workshop 2024, Hefei, China. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 488(2). 245–262.
2.
Egan, Caoimhe, Sophie X. Song, Zhe Wang, et al.. (2025). Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP/EA4HP/SH workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(6). 1311–1328.
3.
Rai, Shivam, Yang Zhang, Nils Hansen, et al.. (2024). IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells. Blood Advances. 8(5). 1234–1249.
4.
Hansen, Nils, Alexandre Guy, Shivam Rai, et al.. (2024). The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Advances. 8(9). 2312–2325.
5.
Campo, Elı́as, Daan Dierickx, Stefan Dirnhofer, et al.. (2024). Lymphoma Classifications, How to Develop a Future Unified Taxonomy. Journal of Clinical Oncology. 42(27). 3177–3182.
6.
Ondrejka, Sarah L., Catalina Amador, Fina Climent, et al.. (2023). Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(3). 349–365.
7.
Quintanilla-Martı́nez, Leticia, Camille Laurent, Lorinda Soma, et al.. (2023). Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(3). 281–298.
8.
Zamò, Alberto, Michiel van den Brand, Fina Climent, et al.. (2023). The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(3). 317–331.
9.
Davies, John R., Thomas Menter, Damian Wild, et al.. (2023). Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis. Histopathology. 84(3). 525–538.
10.
Climent, Fina, Alina Nicolae, Laurence de Leval, et al.. (2023). Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(3). 333–348.
11.
Konantz, Martina, Margaret S. Williams, Stefan Dirnhofer, et al.. (2023). Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis. Journal of Allergy and Clinical Immunology. 152(4). 1019–1024.
12.
Napoli, Arianna Di, Leticia Quintanilla-Martı́nez, Laurence de Leval, et al.. (2023). Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(3). 299–316.
13.
Ghilardi, Guido, Luciano Cascione, Darius Juškevičius, et al.. (2022). Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers. 14(4). 1018–1018.
14.
Dertinger, Susanne, et al.. (2022). H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(3). 489–497.
15.
Brkić, Šime, Simona Stivala, Jakob Passweg, et al.. (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia. 35(10). 2875–2884.
16.
Zucca, Emanuele, Luciano Cascione, Sämi Schär, et al.. (2020). Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial. Hematological Oncology. 38(5). 715–725.
17.
Ceriani, Luca, Giuseppe Gritti, Luciano Cascione, et al.. (2020). SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Advances. 4(6). 1082–1092.
18.
Meyer, Sara C., Simona Stivala, Anne Baerenwaldt, et al.. (2017). Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms. Bern Open Repository and Information System (University of Bern).
19.
Mauermann, Nora, Christophe von Garnier, Stefan Dirnhofer, et al.. (2008). Interferon-γ Regulates Idiopathic Pneumonia Syndrome, a Th17+CD4+ T-Cell–mediated Graft-versus-Host Disease. American Journal of Respiratory and Critical Care Medicine. 178(4). 379–388.
20.
Mitterlechner, Thomas, Michael Fiegl, H. Mühlböck, et al.. (2006). Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000. Journal of Clinical Pathology. 59(1). 48–55.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nicole Mentens Breakdown of academic impact, for papers by Haiyi Guo Breakdown of academic impact, for papers by Xiaonan Hong Breakdown of academic impact, for papers by Anthony P. Conley Breakdown of academic impact, for papers by Paola Casieri Breakdown of academic impact, for papers by Ingrid Simonitsch‐Klupp Breakdown of academic impact, for papers by Jonathan Keith Killian Breakdown of academic impact, for papers by Amy Harlow Breakdown of academic impact, for papers by Kim Linton